Literature DB >> 17662101

Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study.

Enrique Rey1, Fernando Rodriguez-Artalejo, Miguel Angel Herraiz, Puy Sanchez, Angel Alvarez-Sanchez, Manuel Escudero, Manuel Diaz-Rubio.   

Abstract

BACKGROUND AND AIMS: Prevalence of gastroesophageal reflux symptoms (GERS) increases during pregnancy, but there are no longitudinal studies on western populations examining their incidence in each trimester. Our aim was to describe the natural history of GERS in pregnancy and to ascertain whether pregnancy might be associated with a higher risk of developing GERS 1 yr postpartum.
METHODS: Pregnant women (<12 wk gestation) and age-matched controls were included. A telephone survey was conducted, covering pregnant women at 12, 24, and 36 wk of gestation and at 1 yr postpartum, using a validated questionnaire. Controls were interviewed at baseline and 21 months later.
RESULTS: Data on 263 pregnant women were analyzed. Incidence of GERS was 25.8% (95% confidence interval [CI] 20.1-31.1%) in the first trimester, 24.3% (95% CI 18.1-30.6%) in the second, and 25.5% (95% CI 18.2-32.8%) in the third. Factors associated with developing GERS in the first trimester were South American origin (odds ratio [OR] 2.75, 95% CI 1.30-5.84) and prepregnancy occasional GERS (OR 3.00, 95% CI 1.35-6.66). Risk factors of GERS in the third trimester were cumulative weight gain during pregnancy (OR 1.18, 95% CI 1.04-1.32) and prepregnancy occasional GERS (OR 3.79, 95% CI 1.08-13.24). Incidence of frequent GERS at 1 yr postpartum was higher in pregnant versus control women (4.7%vs 1.3%, P < 0.05).
CONCLUSIONS: Incidence of GERS is similar across the three trimesters of pregnancy. Accumulated weight gain during pregnancy is associated with a higher risk of GERS in the third trimester. Pregnancy might constitute a risk factor for developing GERS 1 yr postpartum.

Entities:  

Mesh:

Year:  2007        PMID: 17662101     DOI: 10.1111/j.1572-0241.2007.01452.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

1.  The safety of histamine 2 (H2) blockers in pregnancy: a meta-analysis.

Authors:  Simerpal Kaur Gill; Lisa O'Brien; Gideon Koren
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

2.  Treatment of gastroesophageal reflux disease during pregnancy.

Authors:  Lauren B Gerson
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-11

3.  Prevalence and risk factors for gastroesophageal reflux in pregnancy.

Authors:  Bhavadharini Ramu; Pazhanivel Mohan; Muthu Subramanian Rajasekaran; Venkataraman Jayanthi
Journal:  Indian J Gastroenterol       Date:  2010-12-02

4.  In vitro fertilization-induced pregnancies predispose to gastroesophageal reflux disease.

Authors:  Ilker Turan; Gul Kitapcioglu; Ege Tavmergen Goker; Gulnaz Sahin; Serhat Bor
Journal:  United European Gastroenterol J       Date:  2015-07-24       Impact factor: 4.623

Review 5.  Adverse effects of long-term proton pump inhibitor therapy.

Authors:  Edward Sheen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

Review 6.  ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

Authors:  Philip O Katz; Kerry B Dunbar; Felice H Schnoll-Sussman; Katarina B Greer; Rena Yadlapati; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2022-01-01       Impact factor: 10.864

Review 7.  The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.

Authors:  David A Johnson; Philip O Katz; David Armstrong; Henry Cohen; Brendan C Delaney; Colin W Howden; Peter Katelaris; Radu I Tutuian; Donald O Castell
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

8.  The effect of Acid-reducing pharmacotherapy on the severity of nausea and vomiting of pregnancy.

Authors:  Simerpal Kaur Gill; Caroline Maltepe; Katayoon Mastali; Gideon Koren
Journal:  Obstet Gynecol Int       Date:  2009-07-01

9.  A prospective longitudinal cohort study: evolution of GERD symptoms during the course of pregnancy.

Authors:  Sara Fill Malfertheiner; Maximilian V Malfertheiner; Siegfried Kropf; Serban-Dan Costa; Peter Malfertheiner
Journal:  BMC Gastroenterol       Date:  2012-09-24       Impact factor: 3.067

10.  Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy.

Authors:  Vicki Strugala; Julian Bassin; Valerie S Swales; Stephen W Lindow; Peter W Dettmar; Edward C M Thomas
Journal:  ISRN Obstet Gynecol       Date:  2012-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.